CSP
MEDP icon

Cary Street Partners’s Medpace MEDP Stock Holding History

Cary Street Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$482K Sell
910
-150
-14% -$69.2K 0.01% 678
2026
Q1 		$509K Hold
1,060
– – 0.01% 591
2025
Q4 		$595K Hold
1,060
– – 0.01% 562
2025
Q3 		$545K Hold
1,060
– – 0.01% 553
2025
Q2 		$333K Sell
1,060
-4
-0.4% -$1.2K 0.01% 642
2025
Q1 		$324K Sell
1,064
-15
-1% -$5.05K 0.01% 629
2024
Q4 		$358K Buy
+1,079
New +$366K 0.01% 577

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cary Street Partners's MEDP Position: Q2 2026 in Review

Cary Street Partners reduced its Medpace (MEDP) stake by 14% in Q2 2026, selling an estimated $69.2K and leaving 910 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #678.

Cary Street Partners first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $595K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Cary Street Partners held 910 shares of Medpace worth $482K as of Q2 2026.
  • Cary Street Partners sold 150 Medpace shares in Q2 2026, an estimated $69.2K.
  • Medpace made up 0.01% of Cary Street Partners's portfolio in Q2 2026, its #678 holding.
  • Cary Street Partners first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Cary Street Partners's Medpace position peaked at $595K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.